Drugs / BIIB076
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03056729 | Feb 2017 → Mar 2020 | Alzheimer disease | Biogen | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BIIB076 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03056729 ↗ |
| Route | Intravenous | “Administered as single intravenous (IV) infusion” NCT03056729 ↗ |